Article

Tapeinou, A, Giannopoulou, E, Simal, C, Hansen, BE, Kalofonos, H, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Vlamis-Gardikas, A and Tselios, T (2018) Design, synthesis and evaluation of an anthraquinone derivative conjugated to myelin basic protein immunodominant (MBP₈₅-₉₉ epitope: Towards selective immunosuppression. European Journal of Medicinal Chemistry, 143. 621 - 631. ISSN 0223-5234

Dargahi, Narges, Katsara, M, Tselios, T, Androutsou, ME, de Courten, Maximilian ORCID: 0000-0001-9997-9359, Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2017) Multiple sclerosis: Immunopathology and treatment update. Brain Sciences, 7 (7). ISSN 2076-3425

Yannakakis, MP, Simal, C, Tzoupis, H, Rodi, M, Dargahi, Narges, Prakash, Monica, Mouzaki, A, Platts, JA, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Tselios, T (2017) Design and synthesis of non-peptide mimetics mapping the immunodominant myelin basic protein (MBP83–96) Epitope to function as T-cell receptor antagonists. International Journal of Molecular Sciences, 18 (6). ISSN 1661-6596

Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Deraos, G, Matsoukas, MT, Day, S, Stojanovska, Lily, Tselios, T, Androutsou, ME and Matsoukas, J (2017) Cyclic citrullinated MBP87–99 peptide stimulates T cell responses: Implications in triggering disease. Bioorganic and Medicinal Chemistry, 25 (2). 528 - 538. ISSN 0968-0896

Deraos, G, Rodi, M, Kalbacher, H, Chatzantoni, K, Karagiannis, F, Synodinos, L, Plotas, P, Papalois, A, Dimisianos, N, Papathanasopoulos, P, Gatos, D, Tselios, T, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Mouzaki, A and Matsoukas, J (2015) Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis. European Journal of Medicinal Chemistry, 101. 13 - 23. ISSN 0223-5234

Day, S, Tselios, T, Androutsou, ME, Tapeinou, A, Frilligou, I, Stojanovska, Lily, Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2015) Mannosylated linear and cyclic single amino acid mutant peptides using a small 10 amino acid linker constitute promising candidates against Multiple Sclerosis. Frontiers in Immunology, 6. ISSN 1664-3224

Tapeinou, A, Androutsou, ME, Kyrtata, K, Vlamis-Gardikas, A, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Matsoukas, J and Tselios, T (2015) Conjugation of a peptide to mannan and its confirmation by tricine sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Analytical Biochemistry, 485. 43 - 45. ISSN 0003-2697

Tseveleki, V, Tselios, T, Kanistras, I, Koutsoni, O, Karamita, M, Vamvakas, S-S, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Dotsika, E, Matsoukas, J, Lassmann, H and Probert, L (2014) Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis. Experimental Neurology, 267. 254 - 267. ISSN 0014-4886

Katsara, M, Deraos, S, Tselios, T, Pietersz, Geoff, Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2014) Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugation. Immunotherapy, 6 (6). 709 - 724. ISSN 1750-743X

Laimou, D, Lazoura, E, Troganis, AN, Matsoukas, MT, Deraos, SN, Katsara, M, Matsoukas, J, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Tselios, T (2011) Conformational studies of immunodominant myelin basic protein 1-11 analogues using NMR and molecular modeling. Journal of Computer - Aided Molecular Design, 25 (11). 1019 - 1032. ISSN 0920-654X

Katsara, M, Yuriev, E, Ramsland, PA, Deraos, G, Tselios, T, Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2008) Mannosylation of mutated MBP83-99 peptides diverts immune responses from Th1 to Th2. Molecular Immunology, 45 (13). 3661 - 3670. ISSN 0161-5890

Conference or Workshop Item

Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Katsara, M, Day, S, Tselios, T and Matsoukas, J (2012) Immunotherapeutic aspects for MS: are we heading in the right direction? In: Progress in MS Research Conference 2011, 26 October 2011-28 October 2011, Melbourne, Australia.